Evidence map›Paper›PMID 38862624›Full record

ArticleInternational journal of impotence research2025

The relationship between Coronavirus Disease-19 (COVID-19) and ischemic priapism: a case-control study.

Khaled Almekaty, Ahmed E Taha, Maged Ragab, Ibrahim M Ibrahim, Ayman Rashed, Ahmed Eid, Amr Moubasher, Mohamed H Zahran

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in International journal of impotence research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Khaled AlmekatyUrology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.ORCID http://orcid.org/0000-0002-9815-7035
Ahmed E TahaMicrobiology and Immunology Unit, Department of Pathology, College of Medicine, Jouf University, Sakaka, 72388, Saudi Arabia. aeattia@ju.edu.sa.ORCID http://orcid.org/0000-0002-5766-4495
Maged RagabUrology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
Ibrahim M IbrahimUrology Department, Zagazig University, Zagazig, Egypt.
Ayman RashedUrology Department, 6th of October University, 6th of October, Egypt.ORCID http://orcid.org/0000-0003-1994-2228
Ahmed EidEmergency and Traumatology Department, Tanta University, Tanta, Egypt.
Amr MoubasherDermatology and Andrology Department, Assiut University, Assiut, Egypt.
Mohamed H ZahranMansoura Urology and nephrology center, Mansoura University, Mansoura, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This multicentre retrospective study was conducted in 3 university hospitals in Egypt between April 2020 and June 2022. The aim was to assess the relation between Coronavirus Disease-19 (COVID-19) and ischemic priapism. Forty-three ischemic priapism patients were diagnosed and divided into two groups (30 in group I with ischemic priapism only, and 13 in group II with both ischemic priapism and COVID-19). Further sub-classification of COVID-19 patients according to the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection severity was done. Cavernosal aspiration was successful in 25 patients (83.3%) in group I and 12 (92.3%) in group II. Long term follow-up proved moderate to severe erectile dysfunction in 6 patients (20.0%) and 1 (7.7%) in group I and II, respectively. All those with severe erectile dysfunction were managed by distal shunt and prepared for penile prosthesis placement. The median duration of ischemic priapism was significantly longer in patients with severe erectile dysfunction [19 vs. 7 h, P = 0.01]. There was no statistically significant difference between both groups regarding patients' age (p = 0.8), required priapism management (p = 0.4), priapism recurrence (p = 0.1), and erectile dysfunction severity (p = 0.5). Ischemic priapism in COVID-19 patients can occur not only in severe, but also in mild or even asymptomatic cases. COVID-19 did not influence the ischemic priapism treatment protocol and post-treatment erectile function. COVID-19 and ischemic priapism seem to have a coincidence relation rather than a causal.

Indexed as

COVID-19IschemiaPenisPriapismAdultCase-Control StudiesEgyptErectile DysfunctionHumansMaleMiddle AgedRetrospective StudiesSARS-CoV-2Severity of Illness Index

Identifiers

PMID38862624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.